Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Marc Phelip

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|January 8, 2016
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)Jean Marc Phelip, Laurent Mineur, Christelle De la Fouchardière, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2016
Laparoscopy could be the best approach to treat colorectal cancer in selected patients aged over 80 years: Outcomes from a multicenter studyLeslie Rinaldi, Mehdi Ouaissi, Gabriele Barabino, et al.
Inflammatory Bowel Diseases|May 3, 2018
Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?Xavier Roblin, Céline Vérot, Stéphane Paul, et al.
Surgical Innovation|November 26, 2015
Improving Surgical Resection of Metastatic Liver Tumors With Near-Infrared Optical-Guided Fluorescence ImagingGabriele Barabino, Jack Porcheron, Michèle Cottier, et al.
Cancers|July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter StudyNicolas Williet, Angelica Petrillo, Gaël Roth, et al.
Inflammatory Bowel Diseases|May 2, 2015
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative ColitisSylvie Pillet, Camille Jarlot, Mathilde Courault, et al.
Inflammatory Bowel Diseases|August 18, 2021
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug LevelsXavier Roblin, Capucine Genin, Stéphane Nancey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2015
Metals distribution in colorectal biopsies: New insight on the elemental fingerprint of tumour tissueLeslie Rinaldi, Gabriele Barabino, Jean-Philippe Klein, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|January 8, 2016
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)Jean Marc Phelip, Laurent Mineur, Christelle De la Fouchardière, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2016
Laparoscopy could be the best approach to treat colorectal cancer in selected patients aged over 80 years: Outcomes from a multicenter studyLeslie Rinaldi, Mehdi Ouaissi, Gabriele Barabino, et al.
Inflammatory Bowel Diseases|May 3, 2018
Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?Xavier Roblin, Céline Vérot, Stéphane Paul, et al.
Surgical Innovation|November 26, 2015
Improving Surgical Resection of Metastatic Liver Tumors With Near-Infrared Optical-Guided Fluorescence ImagingGabriele Barabino, Jack Porcheron, Michèle Cottier, et al.
Cancers|July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter StudyNicolas Williet, Angelica Petrillo, Gaël Roth, et al.
Inflammatory Bowel Diseases|May 2, 2015
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative ColitisSylvie Pillet, Camille Jarlot, Mathilde Courault, et al.
Inflammatory Bowel Diseases|August 18, 2021
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug LevelsXavier Roblin, Capucine Genin, Stéphane Nancey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2015
Metals distribution in colorectal biopsies: New insight on the elemental fingerprint of tumour tissueLeslie Rinaldi, Gabriele Barabino, Jean-Philippe Klein, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.
Pageof 12